Skip to content
business briefs club
  • Home
  • Blog
  • Greatest Of All TimeExpand
    • chet holmes
    • jay abraham
    • tony robbins
business briefs club

news

news

Judge offers Berkshire possible speedy trial over Pilot dispute

By December 2, 2023

Post Content

Read More Judge offers Berkshire possible speedy trial over Pilot disputeContinue

news

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

By December 2, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

Read More Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flopsContinue

news

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

By December 2, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

Read More Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flopsContinue

news

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

By December 2, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

Read More Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flopsContinue

news

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

By December 2, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

Read More Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flopsContinue

news

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

By December 2, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

Read More Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flopsContinue

news

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

By December 2, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

Read More Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flopsContinue

news

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

By December 2, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

Read More Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flopsContinue

news

Exxon Mobil CEO urges COP28 to focus on reducing emissions — not phasing out fossil fuels

By December 2, 2023

Exxon Mobil CEO Darren Woods on Saturday said the “problem statement” that countries need to focus on at the COP28 climate summit is reducing emissions.

Read More Exxon Mobil CEO urges COP28 to focus on reducing emissions — not phasing out fossil fuelsContinue

news

Exxon Mobil CEO urges COP28 to focus on reducing emissions — not phasing out fossil fuels

By December 2, 2023

Exxon Mobil CEO Darren Woods on Saturday said the “problem statement” that countries need to focus on at the COP28 climate summit is reducing emissions.

Read More Exxon Mobil CEO urges COP28 to focus on reducing emissions — not phasing out fossil fuelsContinue

Page navigation

Previous PagePrevious 1 2 3 4 5 6 … 167 Next PageNext

© 2025 business briefs club - WordPress Theme by Kadence WP

  • Home
  • Blog
  • Greatest Of All Time
    • chet holmes
    • jay abraham
    • tony robbins

Terms and Conditions - Privacy Policy